Mixed cellular Hodgkin lymphoma, intrapelv nodes is a subtype of Hodgkin lymphoma characterized by a mixture of cell types, including Reed-Sternberg cells. This condition primarily affects lymphatic tissues in the intrapelvic region, leading to symptoms such as lymphadenopathy, fever, and weight loss. Accurate coding with ICD-10 Code C81.26 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this malignancy.
What is ICD-10 Code C81.26 for Mixed cellular Hodgkin lymphoma, intrapelv nodes?
ICD-10 Code C81.26 specifically denotes Mixed cellular Hodgkin lymphoma located in the intrapelvic nodes. This code is utilized when documenting cases of Hodgkin lymphoma that present with a mixed cellular composition and are localized to the pelvic lymphatic structures. It is crucial for accurate clinical documentation and billing, particularly in oncology settings, to ensure appropriate treatment and resource allocation.
ICD-10 Code C81.26 – Clinical Definition and Explanation of Mixed cellular Hodgkin lymphoma, intrapelv nodes
Mixed cellular Hodgkin lymphoma, intrapelv nodes is a hematological malignancy that arises from lymphoid tissue, characterized by the presence of Reed-Sternberg cells amidst a background of inflammatory cells. The etiology remains unclear, but genetic and environmental factors may contribute. This condition necessitates prompt medical evaluation and intervention due to its potential for systemic spread.
Key Clinical Features:
- Presence of enlarged lymph nodes in the pelvic region.
- Symptoms may include fever, night sweats, and unexplained weight loss.
- Diagnosis typically confirmed through biopsy and histological examination.
- May present with associated symptoms of anemia or thrombocytopenia.
ICD-10 Code C81.26 for Mixed cellular Hodgkin lymphoma, intrapelv nodes – SOAP Notes & Clinical Use
In clinical workflows, ICD-10 Code C81.26 is integral for documenting the diagnosis of Mixed cellular Hodgkin lymphoma affecting the intrapelvic nodes. It aids in capturing patient symptoms, assessments, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
What Does ICD-10 Code C81.26 for Mixed cellular Hodgkin lymphoma, intrapelv nodes Mean in SOAP Notes?
ICD-10 Code C81.26 connects subjective patient reports and objective clinical findings to a formal diagnosis of Mixed cellular Hodgkin lymphoma in the intrapelvic nodes. This code is vital for maintaining continuity of care, supporting accurate billing, and adhering to EHR documentation standards.
Treatment Options for ICD-10 Code C81.26 – Mixed cellular Hodgkin lymphoma, intrapelv nodes
Management of Mixed cellular Hodgkin lymphoma, intrapelv nodes typically requires hospitalization for chemotherapy and supportive care. Early intervention is crucial to improve outcomes.
Antibiotic Therapy:
- Not applicable as this is not an infectious condition.
Supportive Care:
- Management of symptoms such as pain and nausea.
- Nutritional support to address weight loss.
- Psychosocial support for emotional well-being.
Infection Control:
- Standard precautions to prevent infections during chemotherapy.
- Monitoring for febrile neutropenia.
How to Document Symptoms of Mixed cellular Hodgkin lymphoma, intrapelv nodes (ICD-10 C81.26) in SOAP Notes
Subjective:
- Patient reports persistent fatigue and night sweats.
- History of unexplained weight loss over the past month.
- Complaints of pelvic discomfort and swelling.
- No known allergies reported.
Objective:
- Physical examination reveals enlarged lymph nodes in the pelvic region.
- Vital signs: Temperature 101°F, pulse 90 bpm, blood pressure 120/80 mmHg.
- Laboratory results show anemia with hemoglobin at 10 g/dL.
- Imaging studies indicate lymphadenopathy in the pelvic area.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Mixed cellular Hodgkin lymphoma, intrapelv nodes (ICD-10 Code C81.26)
Assessment:
- Diagnosis: Mixed cellular Hodgkin lymphoma, intrapelv nodes, Stage II.
- ICD-10 Code: C81.26.
- Contributing factors include age and possible genetic predisposition.
- Patient presents with significant systemic symptoms.
Plan:
- Initiate chemotherapy regimen as per oncology guidelines.
- Schedule follow-up appointments for monitoring treatment response.
- Educate patient on potential side effects and supportive care measures.
- Consider referral to a nutritionist for dietary support.
Treatment & Plan Section for ICD-10 Code C81.26 – Mixed cellular Hodgkin lymphoma, intrapelv nodes
- First-line treatment typically includes ABVD chemotherapy regimen (Adriamycin, Bleomycin, Vinblastine, Dacarbazine).
- Non-pharmacologic strategies include nutritional counseling and psychosocial support.
- Monitoring includes regular CBC checks and imaging studies to assess treatment response.
- Follow-up practices involve scheduling visits every 1-3 months during treatment.
Using ICD-10 Code C81.26 for Mixed cellular Hodgkin lymphoma, intrapelv nodes in Billing & SOAP Note Compliance
- Select appropriate subcodes based on clinical severity or complications.
- Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
- Ensure treatment plans align with clinical guidelines to support justified billing.
- Commonly billed CPT codes include those for chemotherapy administration and imaging studies.
Related ICD-10 Codes Often Used with Mixed cellular Hodgkin lymphoma, intrapelv nodes
- C81.25 – Mixed cellular Hodgkin lymphoma, cervical nodes
- C81.24 – Mixed cellular Hodgkin lymphoma, axillary nodes
- C81.29 – Other mixed cellular Hodgkin lymphoma
ICD-10 Code C81.26 in Medical Billing and Insurance for Mixed cellular Hodgkin lymphoma, intrapelv nodes
ICD-10 Code C81.26 is critical in medical billing, particularly in hospital, ER, or oncology care settings.
Billing Notes:
- Ensure accurate documentation of diagnosis and treatment plans to support claims.
- Use this code in conjunction with relevant CPT codes for chemotherapy and imaging.
- Maintain clear records of patient symptoms and treatment responses for audits.
- Document any complications or comorbidities that may affect billing.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 77014 | Radiologic guidance for placement of a catheter. |
| 85025 | Complete blood count with differential. |
| 71260 | CT scan of the chest, with contrast. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C81.26 for Mixed cellular Hodgkin lymphoma, intrapelv nodes
What are the common symptoms of Mixed cellular Hodgkin lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and itching.
How is Mixed cellular Hodgkin lymphoma diagnosed?
Diagnosis typically involves a physical examination, imaging studies, and a biopsy of the affected lymph nodes to confirm the presence of Reed-Sternberg cells.
What treatment options are available for this condition?
Treatment usually involves chemotherapy, radiation therapy, or a combination of both, depending on the stage of the disease and patient health.
Is Mixed cellular Hodgkin lymphoma curable?
Yes, with appropriate treatment, many patients achieve remission, and the prognosis is generally favorable, especially in early stages.
